U.S. Consumer Finance Stock News

Southwest Gas Holdings (SWX) delivered a sharp improvement in profitability this year, with net profit margins rising to 9.6% from last year’s 3.4% and annual earnings growth hitting 46.2%. That performance stands out after five years of declining earnings. Shares now trade at $78.83, a significant premium to the estimated fair value of $40.31 based on discounted cash flow. With the company expected to grow earnings at 13.4% per year and revenue at 3.5% per year, both well below broader US...

W&T Offshore (WTI) remains unprofitable, with losses compounding at an average rate of 24.6% per year over the past five years. The company’s net profit margin has not improved. However, earnings are forecast to grow 64.67% per year, which could put W&T Offshore on track for potential profitability within the next three years if targets are met. This rapid expected earnings growth is encouraging investors to weigh ongoing financial risks against the possibility of a turnaround based on...

Franklin Covey (FC) reported a mixed performance for the latest period. While the company’s annual earnings have grown by 21.2% over the past five years, earnings turned negative over the last twelve months, hurt by a one-off $6.7 million loss that weighed on overall results. With the net profit margin down from 8.1% to 1.1% and revenue now forecast to grow just 3.8% per year, which is well below the 10.4% pace expected for the broader US market, investors are left weighing slower growth...

Albany International (AIN) posted a net loss that has widened at an average rate of 13.6% annually over the past five years, with profit margins showing no signs of improvement. However, forecasts call for annual earnings growth of 107.38% and a path to profitability within the next three years. While revenue is expected to grow 5% a year, which is slower than the US market average of 10.4%, investors are weighing the valuation discount and projected profit surge against a backdrop of...

Dutch Bros (BROS) posted a net profit margin of 4%, up from 2.5% a year ago, as the company’s earnings surged by 105.3% over the past year compared to its five-year average annual growth rate of 79.9%. Revenue is projected to keep rising, with forecasts calling for 19.4% annual growth, which outpaces the broader US market’s 10.4%. Analysts see annual EPS growth of around 31.3% for the next three years, compared to 15.8% for the market. These results reflect continued margin improvement and...

Texas Pacific Land (TPL) posted a net profit margin of 61.7%, down from last year’s 65.3%, with annual earnings growth slowing to 6.2% from its five-year average of 17.2%. Despite this moderation, the stock trades at $1,011.13 and commands a steep 48.8x earnings multiple. This is well above the US oil and gas industry average of 12.8x and the peer average of 15x, and far exceeds a modeled fair value of $544.63. While the company’s robust long-term earnings track record stands out, high...

Amplitude (AMPL) is projected to grow revenue by 12.4% per year, outpacing the broader US market expectation of 10.4%. The company remains unprofitable and is forecast to stay that way over the next three years, with losses having increased at an average rate of 15.4% annually over the past five years. Net profit margin has not improved, and Amplitude has not produced high-quality past earnings. Investors are weighing the potential for rapid revenue growth and an appealing valuation against...

DraftKings (DKNG) is drawing fresh scrutiny from investors as multiple analyst downgrades highlight issues such as choppy sports outcomes, softer iGaming performance, and the threat of higher state taxes. See our latest analysis for DraftKings. The string of analyst downgrades and legal headlines comes as DraftKings shares have struggled, with a 30-day share price return of -15.1% and a year-to-date drop of nearly 23%. Over the last year, total shareholder return has been a disappointing...

Semrush Holdings (SEMR) is currently unprofitable, but the company has managed to reduce its losses at an average rate of 25.7% per year over the past five years. With forecasts pointing to profitability within three years and earnings expected to grow 117.06% annually alongside 13.8% annual revenue growth, investors are eyeing both the improving trend and SEMR's discounted share price as key rewards in this earnings cycle. See our full analysis for Semrush Holdings. Now, let's see how these...

Pennant Group (PNTG) has continued its strong track record, with earnings forecast to grow by 30.38% per year and revenue expected to rise 16.6% annually, both comfortably ahead of US market averages. Over the past five years, the company delivered annual earnings growth of 29.1%, while profit margins held steady at 3.2%. Investors will note the stock trades at a 30.8x Price-To-Earnings ratio, which is higher than most healthcare peers but below the average of its direct competitors. The...

Borr Drilling (NYSE:BORR) posted standout earnings growth over the last five years, averaging a 56% rise annually and turning profitable with a net profit margin of 7.1% this year, down from 8.7% a year ago. However, the outlook has taken a sharp turn, with analysts projecting earnings to drop by 83.4% per year and revenue to decline 0.4% annually over the next three years. The stock currently trades at $3.21, well below its estimated fair value of $6.44. Its price-to-earnings ratio stands at...

In the past week, BridgeBio Pharma reported third-quarter earnings with revenue rising to US$120.7 million, primarily driven by strong sales of its U.S. Attruby product, and released highly positive topline Phase 3 clinical trial results for BBP-418 in limb-girdle muscular dystrophy type 2I/R9. These updates were accompanied by announcements of further regulatory milestones and trial initiations, underlining BridgeBio’s advancing pipeline and deepening clinical momentum. We'll examine how...

Newmark Group, Inc. recently reported third quarter 2025 results with revenue of US$863.46 million and net income of US$46.15 million, both higher than the prior year, and raised its full-year 2025 guidance to a revenue range of US$3.18 billion to US$3.33 billion, which represents an 18.5% increase at the midpoint. An interesting development is Newmark's expansion of its Property and Facilities Management business into India, appointing experienced executive Sathish Rajendren to lead its...

Exxon Mobil raised its fourth-quarter dividend by 4% to US$1.03 per share and repurchased over 46 million shares in the past quarter, returning a total of US$9.4 billion to shareholders alongside record oil production from key assets in Guyana and the Permian Basin. Gregory C. Garland, former Chair and CEO of Phillips 66, joined the board, bringing additional industry expertise as Exxon Mobil considers shifts in global operations and regulatory environments. We'll explore how Exxon's boosted...

Caris Life Sciences (CAI) is currently unprofitable, with no clear trend in net profit margin or earnings reported for the past year or five years. Analysts forecast revenue growth at an impressive 21% per year and earnings growth of 129.25% per year, predicting the company will reach profitability within three years. Shares currently trade at $24.61, notably below the estimated fair value of $48.22. While its Price-To-Sales Ratio of 10.7x is higher than the US biotech industry average, it...

Albemarle (ALB) remains unprofitable, with reported losses having increased at an average rate of 22.5% per year across the last five years and no improvement shown in net profit margins in its most recent filing. Despite these challenges, the company’s earnings are forecast to rebound sharply at a predicted 66.75% annual growth rate, with profitability expected within three years. Revenue is projected to climb by 8.5% per year, which is slower than the US market average of 10.4%. See our...

Accuray (ARAY) has remained unprofitable, with losses deepening at an annual rate of 28.3% over the past five years. While revenue is projected to grow at 4.4% per year, which is slower than the broader US market’s 10.4% average, earnings are expected to rise sharply at 116.63% per year. This sets the company on course to become profitable within three years. With a Price-To-Sales Ratio of 0.3x and the current share price trading below the estimated fair value of $5.17, investors are keeping...

Ferroglobe (GSM) has narrowed its losses over the past five years, cutting them by 19.5% annually. Although the company remains unprofitable, analysts expect GSM to swing to profitability within three years, with earnings set to grow 118.82% per year and revenue forecast to rise 13.6% per year. Both trends outpace the broader US market. Shares currently trade at $4.14, well below the estimated fair value of $18.98, tilting the balance of rewards toward both value and strong growth...

Enhabit (EHAB) has posted increasing losses over the last five years, with annual losses expanding at a rate of 55.2%. Revenue is expected to grow at 5.5% per year, which trails the 10.4% annual growth forecast for the broader US market. Despite these ongoing losses, EHAB is projected to turn profitable within the next three years. Earnings are forecast to grow at 15.3% annually. See our full analysis for Enhabit. Next, let’s see how these latest figures compare to the narratives commonly...

Talos Energy (TALO) remains unprofitable, with forecasts calling for continued losses over the next three years and revenue projected to decline at an annual rate of 3.4%. Over the past five years, the company has narrowed its losses by 28.1% per year, but has not yet shown improved earnings margins due to persistent negative results. While near-term prospects remain pressured, investors may see potential amid ongoing loss reduction and a significant valuation discount compared to peers. See...

Bumble (BMBL) faces a mixed outlook this earnings season, with revenue forecast to decline by 5.2% per year over the next three years and net losses growing at an annual rate of 61.9% over the past five years. Despite the current losses, earnings are expected to surge by 101.57% annually, with profitability anticipated within the next three years. Investors may view Bumble's below-average Price-to-Sales Ratio and trading price, along with minor risks and a limited risk profile, as potential...

Arko (ARKO) reported a net profit margin of 0.2%, flat compared to last year, as earnings fell by an average of 8.3% per year over the past five years and continued to decline in the most recent period. Revenue is forecast to shrink at a pace of 2.6% per year over the next three years. However, earnings are projected to rebound, with analysts expecting annual growth of 16.5%, which could outpace the broader US market's anticipated 15.8% a year. Despite recent margin pressures and a high...

Adaptive Biotechnologies (ADPT) is forecast to grow its revenue at 13.6% per year, outpacing the broader US market’s 10.4% outlook. Despite this top-line momentum, the company remains unprofitable and is expected to stay in the red for the next three years. Over the last five years, losses have decreased at a rate of 2.6% per year, but net margins have yet to show sustained improvement. See our full analysis for Adaptive Biotechnologies. The next section examines how these results compare...

D-Market Elektronik Hizmetler ve Ticaret (NasdaqGS:HEPS) remains unprofitable, with losses having widened over the past five years at an average rate of 4.4% annually. Despite the ongoing lack of positive net margin, analysts now project a transition to profitability within three years, while revenue is forecast to accelerate at 27.7% per year, well ahead of the broader US market’s 10.4% pace. Coupled with earnings growth expectations of 143.66% per year and a share price of $2.31 trading at...